![Andrew Shales](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Shales
Amministratore Delegato presso
Key Positioning Ltd.
Profilo
Andrew D.
Shales is currently the Chief Executive Officer at Key Positioning Ltd. and Resilia Pharmaceuticals, Inc. He previously served as the Chief Operating Officer & Secretary at Multi-Link Telecommunications, Inc. and as the Chief Operating Officer at Auriga Laboratories, Inc. He also held the position of Chief Operating Officer & Secretary at Auriga Laboratories, Inc. from 2006 to 2007.
Shales received his undergraduate degree from King's College (Pennsylvania) in 1986.
Posizioni attive di Andrew Shales
| Società | Posizione | Inizio |
|---|---|---|
Key Positioning Ltd. | Amministratore Delegato | - |
Resilia Pharmaceuticals , Inc.
 Resilia Pharmaceuticals , Inc. Pharmaceuticals: MajorHealth Technology Resilia Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on acquiring, licensing, and developing high-value but underpromoted and late-stage therapeutics. The company is based in Atlanta, GA. The company supports patients and healthcare providers by offering FDA-approved products such as Ecoza® (econazole nitrate 1% topical foam), Recedo® (topical gel), Neocera™ (advanced cream), and Neosalus® (advanced cream, foam, or lotion), which are available through retail pharmacies and wholesalers. Resilia Pharmaceuticals provides responsible pricing programs and comprehensive resources for physicians and patients, including prescribing information, savings coupons, and channels for reporting adverse events or product quality concerns. The CEO of the company is Andrew D. Shales. | Amministratore Delegato | - |
Precedenti posizioni note di Andrew Shales
| Società | Posizione | Fine |
|---|---|---|
Auriga Laboratories, Inc.
 Auriga Laboratories, Inc. BiotechnologyHealth Technology Engages in the commercialization, licensing and development of prescription pharmaceutical products | Direttore operativo | 05/11/2007 |
Multi-Link Telecommunications, Inc.
 Multi-Link Telecommunications, Inc. Wireless TelecommunicationsCommunications Provides integrated voice and fax messaging services for small and medium sized businesses | Direttore operativo | 21/07/2006 |
Auriga Laboratories, Inc. /Old/
 Auriga Laboratories, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Direttore operativo | 20/07/2006 |
Formazione di Andrew Shales
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
20
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Multi-Link Telecommunications, Inc.
Multi-Link Telecommunications, Inc. Wireless TelecommunicationsCommunications Provides integrated voice and fax messaging services for small and medium sized businesses | Communications |
Auriga Laboratories, Inc. /Old/
Auriga Laboratories, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Health Technology |
King's College (Pennsylvania)
 King's College (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Auriga Laboratories, Inc.
Auriga Laboratories, Inc. BiotechnologyHealth Technology Engages in the commercialization, licensing and development of prescription pharmaceutical products | Health Technology |
Key Positioning Ltd. | |
Resilia Pharmaceuticals , Inc.
Resilia Pharmaceuticals , Inc. Pharmaceuticals: MajorHealth Technology Resilia Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on acquiring, licensing, and developing high-value but underpromoted and late-stage therapeutics. The company is based in Atlanta, GA. The company supports patients and healthcare providers by offering FDA-approved products such as Ecoza® (econazole nitrate 1% topical foam), Recedo® (topical gel), Neocera™ (advanced cream), and Neosalus® (advanced cream, foam, or lotion), which are available through retail pharmacies and wholesalers. Resilia Pharmaceuticals provides responsible pricing programs and comprehensive resources for physicians and patients, including prescribing information, savings coupons, and channels for reporting adverse events or product quality concerns. The CEO of the company is Andrew D. Shales. | Health Technology |
